Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A.K., Thomas, T., Mule, J. and Baker Jr., J.R. (2002) Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells through the Folate Receptor. Pharmaceutical Research, 19, 1310-1316.
http://dx.doi.org/10.1023/A:1020398624602

has been cited by the following article:

• TITLE: Prostate Cancer’s Molecular Imaging by Targeting Based Nanoparticles: An Overview

  AUTHORS: Hossein Heidari, Alireza Salehi Fordoei, Mostafa Saffary, Mehdi Shafiee Ardestani

  KEYWORDS: PLGA, Dendrimer, Nanoparticles Based Drug Delivery or Imaging Agents, Prostate Malignancies

  JOURNAL NAME: Health, Vol.7 No.5, May 20, 2015

  ABSTRACT: Today nanoparticles based drug delivery or imaging agents are extremely being investigated as a very powerful tool in early diagnostics or treatment of different kinds of cancers including prostate malignancies. Among the diverse developing nanomaterials, biocompatible biodegradable dendrimers and chitosan or PLGA (Poly Lactic-co-Glycolic Acid) derivatives are more considered due to their safer profiles. As a result, finding novel prostate imaging agents based on nano sized structures would be of high global interest which will be further discussed in this review.